Role of Cathelicidins in Atherosclerosis and Associated Cardiovascular Diseases

Role of Cathelicidins in Atherosclerosis and Associated Cardiovascular Diseases

Cathelicidins (human LL-37 and rat CRAMP) are multifunctional peptides involved in various cardiovascular conditions. This review integrates the recent findings about the functional involvement of LL-37/CRAMP across atherosclerosis, acute coronary syndrome, myocardial infarction, heart failure, diab...

Full description

Saved in:

Bibliographic Details
Main Authors:	Siarhei A. Dabravolski, Nikolay A. Orekhov, Alexey V. Churov, Irina A. Starodubtseva, Dmitry F. Beloyartsev, Tatiana I. Kovyanova, Vasily N. Sukhorukov, Alexander N. Orekhov
Format:	Article
Language:	English
Published:	MDPI AG 2024-08-01
Series:	Journal of Molecular Pathology
Subjects:	atherosclerosis cathelicidins myocardial infarction heart failure thrombosis coronary syndrome
Online Access:	https://www.mdpi.com/2673-5261/5/3/23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of lipase maturation factor 1 in hypertriglyceridaemia and atherosclerosis: An update
by: Siarhei A Dabravolski, et al.
Published: (2024-10-01)

Cytokines are the Basis of the Development and Suppression of Inflammation in Atherosclerosis
by: Alexander V. Blagov, et al.
Published: (2025-03-01)

Detection of Cathelicidin-1 and Cathelicidin-2 Biomolecules in the Milk of Goats and Their Use as Biomarkers for the Diagnosis of Mastitis
by: Maria V. Bourganou, et al.
Published: (2025-08-01)

Interplay of rheumatoid arthritis and cardiovascular disease: Insights and prospects
by: Anastasia V. Poznyak, et al.
Published: (2025-07-01)

Association between atherosclerosis and the development of multi-organ pathologies
by: Siarhei A Dabravolski, et al.
Published: (2024-12-01)

Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation
by: Alina Delia Popa, et al.
Published: (2024-12-01)

DYNAMIC CHANGES OF GRANULYSIN AND CATHELICIDIN IN CHILDREN AND ADOLESCENTS WITH DIFFERENT FORMS OF PULMONARY TUBERCULOSIS
by: M. M. (Jr) Averbakh, et al.
Published: (2018-11-01)

Elevated serum levels of cathelicidin and β-defensin 2 are associated with basal cell carcinoma
by: Marta Fijałkowska, et al.
Published: (2021-10-01)

Marsupial cathelicidins: characterization, antimicrobial activity and evolution in this unique mammalian lineage
by: Emma Peel, et al.
Published: (2025-04-01)

Vitamin D3 loaded polycaprolactone nanoparticles enhance the expression of the antimicrobial peptide cathelicidin in macrophages
by: Prince N. Dlozi, et al.
Published: (2025-12-01)

Cathelicidins Limit Intracellular <i>Neospora caninum</i>-Infection in Macrophages
by: Franco Fiorani, et al.
Published: (2025-07-01)

Rheumatoid Arthritis: What Inflammation Do We Face?
by: Anastasia V. Poznyak, et al.
Published: (2024-10-01)

Elephant Cathelicidin-Derived Peptides Inhibit Herpes Simplex Virus 1 Infection
by: Haiche Yisihaer, et al.
Published: (2025-06-01)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
by: Karol Majewski, et al.
Published: (2018-12-01)

Antiviral activity of cathelicidins against porcine epidemic diarrhea virus (PEDV): Mechanisms, and efficacy
by: Fatemeh Pashaie, et al.
Published: (2024-12-01)

Cathelicidin in Urinary Tract Diseases: Diagnostic, Prognostic and Therapeutic Potential of an Evolutionary Conserved Antimicrobial Protein
by: Iva Sorić Hosman, et al.
Published: (2024-12-01)

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series
by: A. M. Namitokov, et al.
Published: (2023-12-01)

N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2012-06-01)

Cathelicidin regulates goblet cell mucus secretion and mucus-associated proteins in Citrobacter rodentium-induced colitis
by: Niloofar Mirzadzare, et al.
Published: (2025-12-01)

Endopeptidase O promotes Streptococcus suis immune evasion by cleaving the host- defence peptide cathelicidins
by: Mingjie Jin, et al.
Published: (2023-12-01)

Exploring the Antimicrobial and Immunomodulatory Potential of Gecko-Derived Cathelicidin Gj-CATH5
by: Shasha Cai, et al.
Published: (2025-06-01)

Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice
by: Vagif Ali oglu Gasanov, et al.
Published: (2025-04-01)

ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE
by: A. I. Chesnikova, et al.
Published: (2015-12-01)

Cholesterol of Low-Density Lipoprotein-Containing Circulating Immune Complexes Improves Prognosis of Asymptomatic Carotid Atherosclerosis
by: A. N. Orekhov, et al.
Published: (2024-06-01)

The role of modern antithrombotic agents in cardiovascular disease prevention
by: O. M. Drapkina, et al.
Published: (1970-01-01)

THE INFLUENCE OF MULTIFOCAL ATHEROSCLEROSIS ON LONG-TERM OUTCOMES AFTER ENDOVASCULAR REVASCULARIZATION IN MYOCARDIAL INFARCTION
by: R. S. Tarasov
Published: (2015-02-01)

Splenic Infarction and Myocardial Infarction in A Patient with COVID-19 on Anticoagulant Therapy with Normal D-Dimer Levels
by: M. I. Grusha, et al.
Published: (2024-01-01)

Plasminogen activators in acute management of thrombosis
by: E. O. Taratukhin
Published: (2013-06-01)

The role of human β-defensin 2 (HbD-2) and cathelicidin (LL-37) in the local protection of the upper respiratory tract in children with allergic rhinitis and bronchial asthma
by: Yu.K. Bolbot, et al.
Published: (2021-03-01)

KAWASAKI SYNDROME WITH INVOLVEMENT OF CARDIOVASCULAR SYSTEM: LONG-TERM CONSEQUENCES
by: O. G. Shirinskaya, et al.
Published: (2013-07-01)

GENETIC MARKERS OF METABOLIC SYNDROME AND CORONARY ATHEROSCLEROSIS IN YAKUTIA INHABITANTS
by: А. N. Romanova, et al.
Published: (2017-11-01)

Discussion of a new classification for coronary artery disease
by: A. S. Galyavich
Published: (2020-03-01)

Enhanced levels of IL-6 and PAI-1 and decreased levels of MMP-3 in cytomegalovirus seropositive patients with prior myocardial infarction
by: Xinling Xu, et al.
Published: (2025-02-01)

Exosomes as Regulators of Macrophages in Cardiovascular Diseases
by: Marina Soriano-Cruz, et al.
Published: (2024-11-01)

Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease
by: C. Napoli
Published: (2011-12-01)

CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2015-11-01)

Difficult Diagnosis: Acute Myocarditis or Myocardial Ischemia in an Infant with Thrombophilia? Clinical Case
by: Oksana A. Vazemiller, et al.
Published: (2017-04-01)

Association of RS1800470 polymorphic variants of the transforming growth factor β1 (TGF-β1) gene with the severity of coronary atherosclerosis
by: D. A. Brusentsov, et al.
Published: (2018-11-01)

CARDIAC MAGNETIC RESONANCE IMAGING IN DIFFERENTIAL DIAGNOSTICS OF ACUTE CORONARY SYNDROME IN PATIENTS WITH NON-OBSTRUCTION CORONARY ATHEROSCLEROSIS
by: V. V. Ryabov, et al.
Published: (2017-12-01)

Myocardial infarction with nonobstructive coronary arteries: current state of the problem and diagnostic approaches
by: A. S. Shilova, et al.
Published: (2019-04-01)